SELECTION SUMMARY
도입 판단 요약
Monthly Nirsevimab Receipt and Intent Among Females Aged 18-49 Years Who Have a Baby <8 Months, Are Currently Pregnant, or Are Trying to Get Pregnant. • Using data from the National Immunization Survey-Adult COVID Module (NIS-ACM), monthly estimates of receipt and intent for baby’s receipt of nirsevimab reported by females aged 18-49 years with infants under the age of 8 months, females aged 18-49 years who are currently pregnant, and females aged 18-49 years who are currently trying to get pregnant. • The NIS-ACM is an ongoing random-digit-dial cellular telephone survey of households with adults 18 years and older.
이 제품의 적합 용도와 제한 조건은 아직 검수하지 않았습니다. 태그와 카테고리는 찾아가는 길이지 적합성 보증이 아닙니다.